Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
International Journal of Cardiology|September 29, 2022
Optimization of pharmacotherapies for ambulatory patients with heart failure and reduced ejection fraction is associated with improved outcomesMarilyne Jarjour, Jacinthe Leclerc, Nadia Bouabdallaoui, et al.
European Journal of Clinical Pharmacology|December 20, 2024
A Study Of the effect of Sex on drug dosing, concentrations, and pharmacogenomics in the Montreal Heart Institute Hospital Cohort (SOS-PGx): methodology and research progressMarc-Olivier Pilon, Jessica Hindi, Isabelle St-Jean, et al.
Circulation. Cardiovascular Genetics|September 13, 2014
CKM and LILRB5 are associated with serum levels of creatine kinaseMarie-Pierre Dubé, Rosa Zetler, Amina Barhdadi, et al.
ESC Heart Failure|June 23, 2022
Pharmacogenomic study of heart failure and candesartan response from the CHARM programmeMarie-Pierre Dubé, Olympe Chazara, Audrey Lemaçon, et al.
Clinical Cardiology|March 16, 2018
Rationale, design, and preliminary results of the Quebec Warfarin Cohort StudySylvie Perreault, Payman Shahabi, Robert Côté, et al.
Pharmacogenomics|April 28, 2018
A prospective study of the impact of AGTR1 A1166C on the effects of candesartan in patients with heart failureSimon de Denus, Marie-Pierre Dubé, René Fouodjio, et al.
Nature Genetics|April 30, 2014
Rare and low-frequency coding variants in CXCR2 and other genes are associated with hematological traitsPaul L Auer, Alexander Teumer, Ursula Schick, et al.
Circulation. Genomic and Precision Medicine|February 9, 2021
Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOTMarie-Pierre Dubé, Marc-André Legault, Audrey Lemaçon, et al.
Pageof 10